• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parexel and ASAN accelerate Korea-based drug development

Parexel and ASAN accelerate Korea-based drug development

February 1, 2012
CenterWatch Staff

CRO Parexel International has joined with ASAN Medical Center (AMC), based in Seoul, Korea, to offer clinical trial sponsors based regionally and internationally access to clinical trial services throughout Asia, with a focus on early phase development.

“With ASAN Medical Center's leadership in clinical trials, in-depth expertise, state-of-the art facilities and a renowned network of hospitals, we believe our alliance will offer unique advantages to the Korean biopharmaceutical industry,” said Mark A. Goldberg, M.D., COO of Parexel. “We look forward to contributing to continued drug development growth in the region through shared learnings, technologies and best practices."

The AMC Clinical Trial Center, which opened in 2002, was designated as the Regional Clinical Trial Center by the Korean Ministry for Health, Welfare and Family Affairs in 2006. The government's investment made it possible for the center to rapidly build infrastructure. 

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing